Dow Down 0.18% Nasdaq Up 0.39%

Pernix Therapeutics Holdings, Inc. (PTX)

-NGM
8.32 0.37(4.26%) Sep 2, 4:00PM EDT
Prev Close:8.69
Open:8.85
Bid:N/A
Ask:9.07 x 100
1y Target Est:8.67
Beta:1.74
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:8.05 - 8.85
52wk Range:1.68 - 9.56
Volume:420,534
Avg Vol (3m):539,544
Market Cap:316.52M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTX

Comparison

Symbol% ChgMkt Cap
PTXDown 4.26%316.52M
JNJ291.50B
PFE185.53B

Key Statistics

Forward P/E (1 yr):22.49
P/S (ttm):4.20
Ex-Dividend Date:21-Aug-01

Analysts

Annual EPS Est (Dec-14) :-0.31
Quarterly EPS Est (Sep-14) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback